Massmutual Trust CO Fsb Krystal Biotech, Inc. Transaction History
Massmutual Trust CO Fsb
- $3.28 Billion
- Q2 2024
A detailed history of Massmutual Trust CO Fsb transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 29 shares of KRYS stock, worth $5,345. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29
Previous 17
70.59%
Holding current value
$5,345
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KRYS
# of Institutions
263Shares Held
21.5MCall Options Held
462KPut Options Held
723K-
Avoro Capital Advisors LLC New York, NY2.56MShares$471 Million5.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$448 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$333 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.51MShares$278 Million10.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$182 Million9.23% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.73B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...